Radiosynthesis Equipment Market

Radiosynthesis Equipment Market Size and Share Forecast Outlook 2025 to 2035

The Radiosynthesis Equipment Market is estimated to be valued at USD 1.5 billion in 2025 and is projected to reach USD 3.1 billion by 2035, registering a compound annual growth rate (CAGR) of 7.5% over the forecast period.

Quick Stats for Radiosynthesis Equipment Market

• Radiosynthesis Equipment Market Value (2025): USD 1.5 billion
• Radiosynthesis Equipment Market Forecast Value (2035): USD 3.1 billion
• Radiosynthesis Equipment Market Forecast CAGR: 7.5%
• Leading Segment in Radiosynthesis Equipment Market in 2025: Fully Automated (55.0%)
• Key Growth Regions in Radiosynthesis Equipment Market: North America, Asia-Pacific, Europe
• Top Key Players in Radiosynthesis Equipment Market: Siemens, GE, IBA Radiopharma Solutions, Eckert & Ziegler Group, Synthra, Sumitomo, Sofie Biosciences, Scintomics, Trasis, Posi-Med, ATS Automation Tooling Systems, PerkinElmer

Radiosynthesis Equipment Market Key Takeaways

Metric	Value
Radiosynthesis Equipment Market Estimated Value in (2025E)	USD 1.5 billion
Radiosynthesis Equipment Market Forecast Value in (2035F)	USD 3.1 billion
Forecast CAGR (2025 to 2035)	7.5%

Why is the Radiosynthesis Equipment Market Growing?

The Radiosynthesis Equipment market is witnessing steady growth due to the increasing demand for radiopharmaceuticals in diagnostic and therapeutic applications. The adoption of advanced imaging techniques in nuclear medicine and personalized therapy has significantly driven the requirement for reliable and efficient radiosynthesis systems.

Investments in hospital infrastructure, rising prevalence of chronic diseases, and the expansion of PET and SPECT imaging facilities are creating a favorable environment for market growth. The shift towards automation in radiopharmaceutical production is improving accuracy, reducing human error, and enhancing safety, further supporting market expansion.

Additionally, regulatory emphasis on quality and reproducibility in radiopharmaceutical preparation has encouraged the use of advanced equipment With the ongoing focus on molecular imaging and targeted radiotherapy, the market is poised for continued growth, offering opportunities for technology upgrades and the development of innovative automated solutions that streamline production processes and improve operational efficiency in clinical and research settings.

Segmental Analysis

The radiosynthesis equipment market is segmented by product type, end user, and geographic regions. By product type, radiosynthesis equipment market is divided into Fully Automated and Semi-Automated. In terms of end user, radiosynthesis equipment market is classified into Hospitals, Radiology Centers, Diagnostic Laboratories, Research Centers, and Ambulatory Surgical Centers. Regionally, the radiosynthesis equipment industry is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.

Insights into the Fully Automated Product Type Segment

The Fully Automated product type is projected to account for 55.00% of the Radiosynthesis Equipment market revenue in 2025, positioning it as the leading segment. Its growth has been driven by the increasing emphasis on precision and reproducibility in radiopharmaceutical production, which reduces the risk of contamination and human error.

Fully automated systems provide enhanced efficiency by integrating complex chemical synthesis steps into a single workflow, minimizing manual intervention, and allowing consistent high-quality output. The segment’s prominence is further supported by the rising need for high-throughput production in hospitals and research institutions.

Ease of compliance with stringent regulatory requirements and the ability to handle a variety of radiopharmaceutical compounds without extensive reconfiguration have also contributed to its adoption As demand for advanced molecular imaging and radiotherapy agents grows, fully automated systems are expected to maintain their leadership position by offering scalable, safe, and reliable solutions for both clinical and research applications.

Insights into the Hospitals End-Use Segment

The Hospitals end-use segment is expected to hold 35.00% of the Radiosynthesis Equipment market revenue in 2025, establishing it as the leading user category. This growth is being fueled by the increasing installation of radiopharmaceutical production facilities within hospital environments to support on-site diagnostic imaging and therapeutic procedures.

Hospitals benefit from enhanced workflow efficiency, improved patient throughput, and reduced dependency on external radiopharmaceutical suppliers. The segment’s prominence is reinforced by the growing use of PET and SPECT imaging in oncology, cardiology, and neurology, which drives consistent demand for high-quality radiopharmaceuticals.

Investment in automated radiosynthesis equipment within hospitals ensures compliance with safety and regulatory standards while allowing flexible production schedules for diverse isotopes The ongoing expansion of hospital infrastructure, combined with rising awareness of molecular imaging and personalized medicine, is expected to sustain the growth of this end-use segment, positioning hospitals as a primary driver for market expansion.

Market Overview

Radiosynthesis Equipment Market Introduction

Radiosynthesis is a completely automated synthesis which includes production of radioactive compounds. The process is carried by various nuclear interface modules which are further protected by the lead shielding and is semi-automatically controlled by the computer.

Modules are set-up differently depending on the synthesis process and type of product. These Radiosynthesis equipment modules are adapted with the synthesis stages consecutively. Radiosynthesis equipment are also used for molecular labeling and formulation and production of radiotracers.

These radioactive tracers are chemical compounds for which atoms are replaced by the radioisotopes. Radioisotopes are used in diagnostic areas with SPECT and PET. Radiosynthesis equipment are easy-to-use and allows scope for customization of radiotracers.

Results obtained by these Radiosynthesis equipment can further also be used for research purposes and therapeutic nuclear medicine. Government support for diagnostic related researches favors the production of radiosynthesis equipment.

For instance, Department of Energy provided around $1 million phase II grant under the SBIR program for developing micro-scale technology for simple and rapid synthesis of PET probes.

Analysis of Radiosynthesis Equipment Market By Key Countries

Country	CAGR
China	10.1%
India	9.4%
Germany	8.6%
Brazil	7.9%
USA	7.1%
UK	6.4%
Japan	5.6%

Country-wise Analysis

The Radiosynthesis Equipment Market is expected to register a CAGR of 7.5% during the forecast period, exhibiting varied country level momentum. China leads with the highest CAGR of 10.1%, followed by India at 9.4%. Developed markets such as Germany, France, and the UK continue to expand steadily, while the USA is likely to grow at consistent rates. Japan posts the lowest CAGR at 5.6%, yet still underscores a broadly positive trajectory for the global Radiosynthesis Equipment Market.

In 2024, Germany held a dominant revenue in the Western Europe market and is expected to grow with a CAGR of 8.6%. The USA Radiosynthesis Equipment Market is estimated to be valued at USD 557.3 million in 2025 and is anticipated to reach a valuation of USD 557.3 million by 2035. Sales are projected to rise at a CAGR of 0.0% over the forecast period between 2025 and 2035. While Japan and South Korea markets are estimated to be valued at USD 80.4 million and USD 51.6 million respectively in 2025.

Key Players in the Radiosynthesis Equipment Market

• Siemens
• GE
• IBA Radiopharma Solutions
• Eckert & Ziegler Group
• Synthra
• Sumitomo
• Sofie Biosciences
• Scintomics
• Trasis
• Posi-Med
• ATS Automation Tooling Systems
• PerkinElmer

Scope of the Report

Item	Value
Quantitative Units	USD 1.5 Billion
Product Type	Fully Automated and Semi-Automated
End User	Hospitals, Radiology Centers, Diagnostic Laboratories, Research Centers, and Ambulatory Surgical Centers
Regions Covered	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country Covered	United States, Canada, Germany, France, United Kingdom, China, Japan, India, Brazil, South Africa
Key Companies Profiled	Siemens, GE, IBA Radiopharma Solutions, Eckert & Ziegler Group, Synthra, Sumitomo, Sofie Biosciences, Scintomics, Trasis, Posi-Med, ATS Automation Tooling Systems, and PerkinElmer

Radiosynthesis Equipment Market by Segments

Product Type:

• Fully Automated
• Semi-Automated

End User:

• Hospitals
• Radiology Centers
• Diagnostic Laboratories
• Research Centers
• Ambulatory Surgical Centers

Region:

• North America
  • USA
  • Canada
  • Mexico
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Nordic
  • BENELUX
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan & Baltic
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia & New Zealand
  • Rest of South Asia and Pacific
• Middle East & Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Turkiye
  • South Africa
  • Other African Union
  • Rest of Middle East & Africa